NEWS 84 FEED & ADDITIVE MAGAZINE October 2022 Evonik, one of the world's leading specialty chemicals companies, has opened a new Innovation Hub at its Allentown, Pa., site. The Hub consists of several state-of-the-art testing and processing labs as well as a pilot plant. It also features a newly designed collaboration space to support a hybrid and creative work environment. The Innovation Hub is part of a broader globalization strategy for Research, Development & Innovation (RD&I) at the Germany-based company. "We are strengthening regional RD&I hubs in Asia and North America to benefit from innovative ideas outside of Europe and be closer to our customers in those regions," said Evonik Chief Financial Officer Ute Wolf at the Ribbon Cutting Ceremony for the Allentown Innovation Hub. "The new Hub will transform the Allentown site into our premier center for research, business, and innovation in North America." By 2030, Evonik aims to invest more than $3 billion in Next Generation Solutions - products with superior sustainability benefits. Evonik will invest an additional $700 million in Next Generation Technologies to optimize production processes and infrastructure and avoid CO2 emissions. Evonik opens new Innovation Hub in Pennsylvania Synomics, the biological insights technology startup, has confirmed a new partnership with Mars Petcare to produce canine disease risk prediction models. The new partnership will see Synomics utilise its proprietary technology to analyse Mars Petcare’s multi-layer anonymised datasets to develop scoring models for prediction of an individual pet’s risk of developing a condition. The scoring models developed by Synomics will ultimately help improve the wellbeing of pets by enabling deeper insight into a pet’s genetic health and predispositions and its risk factor towards a variety of common diseases, enabling owners to monitor and manage conditions more effectively. Commenting on the partnership, Rebecca Chodroff Foran, Ph.D. (Head of R&D at Wisdom Panel, the world leader in pet genetics, maker of Wisdom Panel™ pet DNA tests, and part of Kinship Partners, Inc., a division of Mars Petcare) said: “Similar to humans, pets suffer from many chronic conditions such as diabetes, kidney disease and arthritis that affect their wellbeing on a daily basis. Early understanding of an individual animal’s risk may enable proactive monitoring by veterinary professionals as well as supporting pet owners with decisions on diet, lifestyle and management.” Peter Kristensen, Synomics’ CEO and Managing Partner at Grosvenor Food & AgTech, Synomics’ main shareholder, said: “Grosvenor has a strong relationship with the Mars organisation and we’re delighted they recognise the value Synomics and its technology can bring to further enhance the great work already happening at Mars. Synomics announces partnership with Mars Petcare
RkJQdWJsaXNoZXIy MTUxNjkxNQ==